Vitiligo Trial
Vitiligo
Not SpecifiedActive
Key Facts
About Well Pharma Medical Research
Well Pharma Medical Research is a US-based clinical research site organization providing trial execution services for pharmaceutical and biotech sponsors. Founded and led by Dr. Eddie Armas, the company operates two dedicated units for early and late-phase trials, supported by an on-site CLIA-certified lab, secure pharmacy, and proficiency with major electronic data capture systems. Its business model is service-based, generating revenue from conducting clinical trials for external partners across indications like dermatology, respiratory, and metabolic diseases. The company's outlook is tied to the robust clinical trial activity in South Florida and its established investigator network.
View full company profileTherapeutic Areas
Other Vitiligo Drugs
| Drug | Company | Phase |
|---|---|---|
| PEP Biologic™ | Intent Biologics | Unknown |
| Adimune | Aditxt | Preclinical |
| Vitiligo Candidate | Teva | Phase 2 |
| Therapeutic Vaccine | 2A Pharma | Pre-clinical |
| CGB-600 | CAGE Bio | Phase 2 |
| AB1001 | Ahammune Biosciences | Phase 1 Completed |
| Novel Immunology Candidate | Teva Pharmaceutical Industries | Phase 2 |
| Opzelura (ruxolitinib cream) | Incyte | Marketed |
| Topical Roflumilast Foam 0.3% | Arcutis Biotherapeutics | Phase 2 |
| SCENESSE® (afamelanotide) | Clinuvel Pharmaceuticals | Phase III |
| EB06 | Edesa Biotech | Phase 1 |